Generics 97

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Captopril manufacturers

97 products found

Filters

97 products found

captopril

Tablets 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam , Sudan
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #16024

A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, Africa, Middle East, CIS, North America, LATAM, and Asia for 50+ years. Key production lines are RX products, OTC, cosmetics, food supplements, and veterinary products. They are produced in GMP-compliant manufacture. The main dosage forms are liquid, solid, and semi-solid. The main therapeutic areas are dermatology, metabolic diseases, and respiratory. The company possesses a branch in Africa.

Manufacturer usually replies in 10 days

captopril

Tablets 25mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16471
The company was formed more than 50 years ago. They have more than 75 products which are grouped into medicines, biocides, medical devices, cosmetics, and food supplements. The products are sold in pharmacies and drugstores in more than 40 counties.

Manufacturer usually replies in 4 days

captopril

Tablets 25, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13316

Manufacturer usually replies in 4 days

captopril

Tablets 12.5 mg, 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11480
The company was founded in the mid-1990s. It has been manufacturing pharmaceutical products and performing related pharmaceutical research and development. They are focused to provide quality products. They cater to all segments like anti allergies, dermatological products, cardiovascular products, etc.

Manufacturer usually replies in 4 days

captopril + hydrochlorothiazide

Tablets (50+25) mg/tab

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #16255
The company is a 100% Greek pharmaceutical company whose major activities are the creation and trading of branded generic pharmaceutical products while maintaining a high level of patient respect and devotion. It is the holder of more than 70 marketing authorizations for pharmaceutical products and the launcher of more than 46 of them.

Manufacturer usually replies in 8 days

captopril

Tablets 12.5 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1178
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe and CIS for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. The company's production lines are GMP-compliant. Main dosage forms include solid oral, suppositories, creams, and gels.

Manufacturer usually replies in 6 days

captopril

Tablets 25mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15094

Manufacturer usually replies in 7 days

captopril + hydrochlorothiazide

Tablets 50 mg + 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12976
Established in the 1970s. They have a worldwide distribution network that provides customers with full sales and service support across 6 continents. They have over 4 decades of manufacturing experience. They are also a UK distributor for a high-speed DTG solution and specialize in folding and bagging systems.

Manufacturer usually replies in 6 days

captopril

Tablets 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12976
Established in the 1970s. They have a worldwide distribution network that provides customers with full sales and service support across 6 continents. They have over 4 decades of manufacturing experience. They are also a UK distributor for a high-speed DTG solution and specialize in folding and bagging systems.

Manufacturer usually replies in 6 days

captopril + hydrochlorothiazide

Tablets 50 mg + 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

captopril

Tablets 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

captopril

Tablets 12.5 mg, 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Captopril, Mylan
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

captopril

Oral solution 5 mg, 25 mg / 5 mL

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13662
With a countrywide distribution network, it has evolved into one of the leading pharmaceutical corporations in the UK. In business since the 1990s. The company maintains the UK's largest Parallel import license portfolio, operates a customized specialties production facility, is the country's largest independent generics distributor, and is dedicated to providing everyday value to its customers.

Manufacturer usually replies in 13 days

captopril

Oral solution 5 mg/5 ml, 25 mg/5 ml - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Shelf life: 5 mg/5 ml - 18 months 25 mg/5 ml - 12 months
Manufacturer #15084

Manufacturer usually replies in 18 days

captopril

Tablets 12.5 mg, 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #3044

Manufacturer usually replies in nan days

captopril

Tablets 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO, EU GMP
Manufacturer #21022

Manufacturer usually replies in 8 days

captopril

Tablets 50 mg, 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

captopril

Tablets 12.5 mg, 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

captopril

Tablets 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
PICS
Manufacturer #21831

Manufacturer usually replies in 1 days

captopril

Tablets 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

Want to view all 97 products? Create your free account today!

Captopril Manufacturers

Captopril is an ACE inhibitor class medication that is primarily used to treat hypertension and congestive heart failure, but also cystinuria, diabetic kidney disease, left ventricular dysfunction, and polycystic kidney disease. Manufacturers of captopril medications use it as a standalone ingredient in drug formulations, they also produce medications wherein it is coupled with hydrochlorothiazide. Captopril suppliers market the drug as 5mg, 12.5mg, 25mg, and 50mg tablets. The developer and earliest manufacturer of captopril was Bristol-Myers Squibb, who first began marketing it following FDA approval in 1981. The supplier held marketing exclusivity rights to the drug until 1996. Since then, other pharmaceutical producers and distributors joined the market for the drug with their formulations. Currently among the largest captopril manufacturers are companies Farmhispania, Egis Pharmaceuticals, and Wockhardt, whereas major captopril suppliers include Teva, Mylan, Stada, and Sanofi. Captopril suppliers and distributors market both generic and trade name formulations of the drug.

How Does Captopril Work?

Although ACE inhibitors bind to both domains and block their action, they are far more effective against the C-domain and have a much higher affinity for it. One of the few ACE inhibitors that is not a prodrug, captopril competes with ATI for binding to ACE and prevents ATI's conversion to ATII by enzymatic proteolysis. By blocking ATII's pressor actions, as were discussed in the Pharmacology section above, lowering ATII levels in the body lowers blood pressure. A loss of the feedback inhibition mediated by ATII on the release of renin and/or the stimulation of reflex mechanisms via baroreceptors are likely the sources of the increase in plasma renin activity that is also brought on by captopril. Compared to ATI, captopril has an affinity for ACE that is around 30,000 times higher.

Wholesale Price of Captopril

The retail prices of captopril medications vary depending on supplier and manufacturer pricing, the quantity of the active ingredient in the formulation and whether it is a generic or trade name medication. Costs per 20 tablets of captopril fall into an approximate range of 1,00 EUR to 5,00 EUR. Costs of Captopril vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Captopril is available for sale from various Captopril vendors at multiple costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Captopril suppliers, on the whole, are in favor of patient aid initiatives.

From Where to Get Captopril?

It is advised to the buyers that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Captopril manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Captopril, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Captopril.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Captopril offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Captopril suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Captopril. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Captopril is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Captopril suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Captopril manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.